COMPARING THE OUTCOMES EXPERIENCED IN SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR KIDNEY OUTCOME TRIALS TO A CANADIAN CHRONIC KIDNEY DISEASE COHORT

被引：0
|
作者：
Yi, Tae Won [1 ,2 ]
Atiquzzaman, Mohammad [3 ]
Zheng, Yuyan [3 ]
Smyth, Brendan [2 ,4 ]
Jardine, Meg [2 ,5 ]
Levin, Adeera [2 ,3 ,6 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[3] BC Prov Renal Agcy, Vancouver, BC, Canada
[4] St George Hosp, Dept Renal Med, Kogarah, NSW, Australia
[5] Concord Repatriat Gen Hosp, Dept Nephrol, Sydney, NSW, Australia
[6] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada
来源：
NEPHROLOGY | 2022年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [31] Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease A Milestone Achieved
    Sarafidis, Pantelis
    Papadopoulos, Christodoulos E.
    Kamperidis, Vasilios
    Giannakoulas, George
    Doumas, Michael
    HYPERTENSION, 2021, 77 (05) : 1442 - 1455
  • [32] Premature Conclusion that Sodium-Glucose Cotransporter-2 Inhibitors Improve Kidney Outcomes in Patients with Heart Failure
    Zhang, Fan
    Zhang, Xianwen
    Zhong, Yifei
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 36 (02): : 325 - 326
  • [33] Effects of sodium-glucose cotransporter-2 inhibitors on chronic kidney disease progression: a multi-state survival model
    Tansawet, Amarit
    Looareesuwan, Panu
    Teza, Htun
    Boongird, Sarinya
    Mckay, Gareth J.
    Attia, John
    Pattanaprateep, Oraluck
    Thakkinstian, Ammarin
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [34] Impact of Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in Kidney Transplant Recipients
    Arnaldi, M.
    Alzaneen, G. K.
    House, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S606 - S607
  • [35] Plausible prediction of renoprotective effects of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney diseases
    Berezin, Alexander E.
    Berezina, Tetiana A.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (02)
  • [36] Role of sodium-glucose cotransporter-2 inhibitors in risk of chronic kidney disease among patients with type 2 diabetes mellitus
    Tung-Sheng Chen
    Teng-Shun Yu
    Cheng-Li Lin
    Chung Y. Hsu
    Wei-Syun Hu
    Journal of Nephrology, 2023, 36 : 713 - 718
  • [37] Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease An Updated Meta-Analysis of Randomized Controlled Trials
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Goldberg, Michael
    Jain, Diwakar
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2020, 28 (03) : 116 - 124
  • [38] Role of sodium-glucose cotransporter-2 inhibitors in risk of chronic kidney disease among patients with type 2 diabetes mellitus
    Chen, Tung-Sheng
    Yu, Teng-Shun
    Lin, Cheng-Li
    Hsu, Chung Y.
    Hu, Wei-Syun
    JOURNAL OF NEPHROLOGY, 2023, 36 (03) : 713 - 718
  • [39] Impact of sodium-glucose cotransporter-2 inhibitors on kidney outcomes in type 2 diabetes: A tertiary center experience
    Tawhari, Mohammed H.
    Aldahash, Raed A.
    Almutairi, Faisal M.
    Albogami, Mahdi S.
    Rokon, Ahmad E.
    Alsomali, Faisal A.
    Alanazi, Khaled H.
    Alshehri, Abdulrahman A.
    Almutairi, Talal H.
    Alharbi, Abdulrahman D.
    Alghamdi, Rayan M.
    Tawhari, Ibrahim H.
    Bin Salih, Salih A.
    JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2023, 30 (04): : 267 - 272
  • [40] Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease
    El Din, Usama Abdel Azim Sharaf
    Salem, Mona Mansour
    Abdulazim, Dina Ossama
    NEFROLOGIA, 2022, 42 (04): : 390 - 403
12345